{"transactions":[{"id":2227486,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":126045,"kind":"person","name":"Sigal Nolan Howard","position":1,"cik":"0001323291","reported_name":"Sigal Nolan Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:12:32.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924322023139/doc4.xml","form_type":"4"}},{"id":2663475,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":126045,"kind":"person","name":"Sigal Nolan Howard","position":1,"cik":"0001323291","reported_name":"Sigal Nolan Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:50:04.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders."}],"balance_after":96000,"derivative":{"exercise_price":1.29,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0000899243-21-024522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924321024522/doc4.xml","form_type":"4"}},{"id":3105365,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":126045,"kind":"person","name":"Sigal Nolan Howard","position":1,"cik":"0001323291","reported_name":"Sigal Nolan Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T20:33:36.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2020. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders."}],"balance_after":12500,"derivative":{"exercise_price":1.15,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-20-017086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924320017086/doc4.xml","form_type":"4"}},{"id":3481228,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":126045,"kind":"person","name":"Sigal Nolan Howard","position":1,"cik":"0001323291","reported_name":"Sigal Nolan Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-21T20:06:44.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 19, 2019. The shares underlying the option are scheduled to vest in equal annual installments over three years from April 2, 2019."}],"balance_after":5000,"derivative":{"exercise_price":0.86,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-19-017793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924319017793/doc4.xml","form_type":"4"}},{"id":3564437,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":126045,"kind":"person","name":"Sigal Nolan Howard","position":1,"cik":"0001323291","reported_name":"Sigal Nolan Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-04T00:22:10.000Z","date":"2019-04-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 2, 2019. The shares underlying the option are scheduled to vest in equal annual installments over three years from April 2, 2019."}],"balance_after":20000,"derivative":{"exercise_price":1.82,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-009894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924319009894/doc4.xml","form_type":"4"}}]}